Biotech
Expedition Therapeutics
Expedition Therapeutics raises $165M Series B at $850M valuation
$165M
Total Raised
Series B
Latest Round
2021
Founded
100+
Employees
Cambridge, MA
1 min read
Quick Facts
Valuation
$850M
Latest Round Size
$165M
Latest Round Date
January 2025
Expedition Therapeutics: Series B Funding Round
Expedition Therapeutics has successfully raised $165M in Series B funding, reaching a valuation of $850M.
Company Overview
Developing novel therapeutics for cardiometabolic diseases
Funding Details
The Series B round was led by Foresite Capital, with participation from Casdin Capital.
Company Information
- Headquarters: Cambridge, MA
- Founded: 2021
- Employees: 100+
- Category: Biotech
Investment
Expedition Therapeutics plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Foresite Capital: Verified investor in Series B
- Casdin Capital: Verified investor in Series B
Key Investors
Foresite Capital
Lead Investor
Verified investor in Series B
Casdin Capital
Investor
Verified investor in Series B
About the Author
Editorial Team
Curated funding news from verified sources
Related Company Reports
Biotech
Orna Therapeutics
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Emma Rodriguez
Oct 23, 2025
0 min read•$251M Series B
Biotech
Forge Biologics
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Sarah Kim
Oct 23, 2025
0 min read•$120M Series C
Biotech
Vir Biotechnology
Vir Biotechnology Raises $250M
Clinical-stage immunology company developing treatments for infectious diseases including COVID-19, hepatitis B, and influenza
Sarah Kim
Oct 23, 2025
0 min read•$250M